Correlation Between Crinetics Pharmaceuticals and Larimar Therapeutics
Can any of the company-specific risk be diversified away by investing in both Crinetics Pharmaceuticals and Larimar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crinetics Pharmaceuticals and Larimar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crinetics Pharmaceuticals and Larimar Therapeutics, you can compare the effects of market volatilities on Crinetics Pharmaceuticals and Larimar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crinetics Pharmaceuticals with a short position of Larimar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crinetics Pharmaceuticals and Larimar Therapeutics.
Diversification Opportunities for Crinetics Pharmaceuticals and Larimar Therapeutics
0.43 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Crinetics and Larimar is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Crinetics Pharmaceuticals and Larimar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Larimar Therapeutics and Crinetics Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crinetics Pharmaceuticals are associated (or correlated) with Larimar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Larimar Therapeutics has no effect on the direction of Crinetics Pharmaceuticals i.e., Crinetics Pharmaceuticals and Larimar Therapeutics go up and down completely randomly.
Pair Corralation between Crinetics Pharmaceuticals and Larimar Therapeutics
Given the investment horizon of 90 days Crinetics Pharmaceuticals is expected to generate 0.37 times more return on investment than Larimar Therapeutics. However, Crinetics Pharmaceuticals is 2.67 times less risky than Larimar Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Larimar Therapeutics is currently generating about -0.17 per unit of risk. If you would invest 5,596 in Crinetics Pharmaceuticals on September 1, 2024 and sell it today you would earn a total of 124.00 from holding Crinetics Pharmaceuticals or generate 2.22% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Crinetics Pharmaceuticals vs. Larimar Therapeutics
Performance |
| Timeline |
| Crinetics Pharmaceuticals |
| Larimar Therapeutics |
Crinetics Pharmaceuticals and Larimar Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Crinetics Pharmaceuticals and Larimar Therapeutics
The main advantage of trading using opposite Crinetics Pharmaceuticals and Larimar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crinetics Pharmaceuticals position performs unexpectedly, Larimar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Larimar Therapeutics will offset losses from the drop in Larimar Therapeutics' long position.| Crinetics Pharmaceuticals vs. Tff Pharmaceuticals | Crinetics Pharmaceuticals vs. Eliem Therapeutics | Crinetics Pharmaceuticals vs. Inhibrx | Crinetics Pharmaceuticals vs. Enliven Therapeutics |
| Larimar Therapeutics vs. Vaxcyte | Larimar Therapeutics vs. Syndax Pharmaceuticals | Larimar Therapeutics vs. Merus BV | Larimar Therapeutics vs. Sutro Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |